| Literature DB >> 16952275 |
Abstract
RNA-interference, the mechanism by which the expression of a specific protein can be reduced or eliminated, has emerged as a potential way to treat disease. RNA-interference effectors, such as small interfering RNA and small hairpin RNA, are double-stranded nucleic acid sequences expressly designed to have homology to sections of the target protein's mRNA, and when present in the cytosol trigger hydrolysis of the mRNA through the RNA-interference pathway. Because RNA-interference effectors are macromolecular and typically polyanionic, their efficacy is poor when not accompanied by a delivery vehicle. This review outlines the RNA-interference mechanism and discusses the delivery of RNA-interference effectors, with an emphasis on synthetic polymer-based delivery systems.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16952275 DOI: 10.1615/critrevtherdrugcarriersyst.v23.i2.30
Source DB: PubMed Journal: Crit Rev Ther Drug Carrier Syst ISSN: 0743-4863 Impact factor: 4.889